COR | LOE | Recommendations |
---|---|---|
1 | A | 1. In patients with AF and an increased risk for stroke who undergo PCI, DOACs are preferred over VKAs in combination with APT to reduce the risk of clinically relevant bleeding.1–5 |
1 | A | 2. In most patients with AF who take oral anticoagulation and undergo PCI, early discontinuation of aspirin (1–4 wk) and continuation of dual antithrombotic therapy with OAC and a P2Y12 inhibitor is preferred over triple therapy (OAC, P2Y12 inhibitor, and aspirin) to reduce the risk of clinically relevant bleeding.1–4,6 |